Tumor Biology

, Volume 36, Issue 2, pp 929–937 | Cite as

RETRACTED ARTICLE: Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology

  • Ehsan Hosseini
  • Behnam Pedram
  • Ali Mohammad Bahrami
  • Seyed Rashid Touni
  • Hamed Zamankhan Malayeri
  • Aram Mokarizadeh
  • Mehdi Pourzaer
  • Maryam Pourzaer
  • Shahram Zehtabian
  • Sheida Mohajer
  • Sharareh Ahmadi
Research Article


The activating KIT marker plays a central role in the pathogenesis, diagnosis, and targeted treatment of systemic mastocytosis (SM). Recent studies have identified the KIT (CD117) as a marker that distinguishes nonneoplastic from neoplastic mast cells in human systemic mastocytosis. In this study, we conclude that immunohistopathology assays for KIT staining pattern are useful complimentary tools for diagnosis and evaluation of prognosis in uterus mast cell tumor (MCT) metastasis to the liver in 10 patients. Uterine and hepatic cytology revealed mast cell neoplasia, which was confirmed as visceral mast cell tumor on postmortem examination. Histological changes of densely packed, poorly differentiated neoplastic mast cells, sheets of neoplastic round to pleomorphic cells that formed nonencapsulated nodules, high mitotic figures, necrosis, and fibrosis were found. In addition, eosinophils were scattered among the mast cells at the periphery of the nodules. These findings indicate tumors of high-grade malignancy with infiltrative cells resembling the uterus MCT in the intraparenchymal and periparenchymal areas of the liver. Immunohistochemically, tumors were positive for KIT. The histopathologic features coupled with the KIT immunoreactivity led to diagnosis of high-grade uterus MCTs. Taken together, these findings suggest that CD117 may play a critical role in early uterus MCT development and may be a stimulatory factor in grade 3 MCT. Therefore, the result has supported our hypothesis that there was an increased opportunity to observe a higher CD117 staining pattern in high-grade MCTs.


Immunohistochemistry Histopathology KIT Neoplasia Uterine Liver 



The authors thank Dr. Javad Javanbakht for his help with this manuscript.

Conflicts of interest



  1. 1.
    Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005;23:749–86.CrossRefPubMedGoogle Scholar
  2. 2.
    Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol. 2005;6:135–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Marone G, Triggiani M, Genovese A, Paulis AD. Role of human mast cells and basophils in bronchial asthma. Adv Immunol. 2005;88:97–160.CrossRefPubMedGoogle Scholar
  4. 4.
    Kube P, Audige L, Kuther K, Welle M. Distribution, density and heterogeneity of canine mast cells and influence of fixation techniques. Histochem Cell Biol. 1998;110:129–35.CrossRefPubMedGoogle Scholar
  5. 5.
    Myles AD, Halliwell REW, Ballauf B, Miller HRP. Mast cell tryptase levels in normal canine tissues. Vet Immunol Immunopathol. 1995;46:223–35.CrossRefPubMedGoogle Scholar
  6. 6.
    Peeters D, Day MJ, Clercx C. Distribution of leucocyte subsets in bronchial mucosa from dogs with eosinophilic bronchopneumopathy. J Comp Pathol. 2005;133:128–35.CrossRefPubMedGoogle Scholar
  7. 7.
    Matsumoto I, Inoue Y, Shimada T, Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J Exp Med. 2001;194:71–8.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yamamoto K. Electron microscopy of mast cells in the venous wall of canine liver. J Vet Med Sci. 2000;62:118.Google Scholar
  9. 9.
    Norrby K. Mast cells and angiogenesis. APMIS. 2002;110(5):355–71.CrossRefPubMedGoogle Scholar
  10. 10.
    Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 2000;436(3):243–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Kawai K, Uetsuka K, Doi K, Nakayama H. The activity of matrix metalloproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPs) in mammary tumors of dogs and rats. J Vet Med Sci. 2006;68(2):105–11.CrossRefPubMedGoogle Scholar
  12. 12.
    Nakaichi M, Yunuki T, Okuda M, Une S, Taura Y. Activity of matrix metalloproteinase-2 (MMP-2) in canine oronasal tumors. Res Vet Sci. 2007;82(2):271–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Romansik EM, Reilly CM, Kass PH, Moore PF, London CA. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol. 2007;44(3):335–41.CrossRefPubMedGoogle Scholar
  14. 14.
    Hosseini E, Pedram B, Bahrami AM, Moghaddam MH, Javanbakht J, Ghomi FE, et al. Cutaneous mast cell tumor (Mastocytoma): cyto- histopathological and haematological investigations. Diagn Pathol. 2014;9:9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Preziosi R, Sarli G, Paltrinieri M. Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours. Vet Res Commun. 2007;31(3):287–96.CrossRefPubMedGoogle Scholar
  16. 16.
    Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990–2001). J Vet Intern Med. 2003;17(5):687–92.CrossRefPubMedGoogle Scholar
  17. 17.
    Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol. 1984;21(5):469–74.CrossRefPubMedGoogle Scholar
  18. 18.
    Hume CT, Kiupel M, Rigatti L, Shofer FS, Skorupski KA, Sorenmo KU. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). J Am Anim Hosp Assoc. 2011;47(1):37–44.CrossRefPubMedGoogle Scholar
  19. 19.
    Brodey RS, Roszel JF. Neoplasms of the canine uterus, vagina and vulva: a clinicopathologic survey of 90 cases. J Am Anim Hosp Assoc. 1967;151:1294–307.Google Scholar
  20. 20.
    Cotchin E. Neoplasia in the dog. Vet Rec. 1954;66:879–88.Google Scholar
  21. 21.
    Baldwin CJ, Roszel JF, Clark TP. Uterine adenocarcinoma in dogs. Compend Contin Educ Pract Vet. 1992;14:731–7.Google Scholar
  22. 22.
    Miller MA, Ramos-Vara JA, Dickerson MF, Johnson GC, Pace LW, Kreeger JM, et al. Uterine neoplasia in 13 cats. J Vet Diagn Invest. 2003;15:515–22.CrossRefPubMedGoogle Scholar
  23. 23.
    Welle MM, Bley CR, Howard J, Rüfenacht S. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol. 2008;19(6):321–39.CrossRefPubMedGoogle Scholar
  24. 24.
    Haines DM, Chelack BJ. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. J Vet Diagn Invest. 1991;3:101–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Sailasuta A, Ketpun D, Piyaviriyakul P, Theerawatanasirikul S, Theewasutrakul P, Rungsipipat A: The Relevance of CD117-immunocytochemistry staining patterns to mutational exon-11 in c-kit detected by PCR from fine-needle aspirated canine mast cell tumor cells. Vet Med Int. 2014;2014:787498, doi:  10.1155/2014/787498.
  26. 26.
    Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29(5):498–504.CrossRefPubMedGoogle Scholar
  27. 27.
    Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma. 1998;30(5–6):459–66.CrossRefPubMedGoogle Scholar
  28. 28.
    Kiupel M, Webster JD, Kaneene JB, Miller R, YuzbasiyanGurkan V. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol. 2004;41:371–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Webster JD, Yuzbasiyan-Gurkan V, Miller RA, Kaneene JB, Kiupel M. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Vet Pathol. 2007;44:298–308.CrossRefPubMedGoogle Scholar
  30. 30.
    Simoes JP, Schoning P. Canine mast cell tumors: a comparison of staining techniques. J Vet Diagn Invest. 1994;6(4):458–65.CrossRefPubMedGoogle Scholar
  31. 31.
    London CA, Kisseberth WC, Galli SJ, Geissler EN, Helfand SC. Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours. J Comp Pathol. 1996;115(4):399–414.CrossRefPubMedGoogle Scholar
  32. 32.
    London CA, Galli SJ, Yuuki T, Hu ZQ, Helfand SC, Geissler EN. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp Hematol. 1999;27(4):689–97.CrossRefPubMedGoogle Scholar
  33. 33.
    London CA, Seguin B. Mast cell tumors in the dog. Vet Clin North Am Small Anim Pract. 2003;33:473–89.CrossRefPubMedGoogle Scholar
  34. 34.
    Brown CA, Chalmers SA. Diffuse cutaneous mastocytosis in a cat. Vet Pathol. 1990;27:366–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Crafts GA, Pulley LT. Generalized cutaneous mast cell tumor in a cat. Feline Pract. 1975;5:57–8.Google Scholar
  36. 36.
    Lin TY, Hamberg A, Pentecost R, Wellman M, Stromberg P. Mast cell tumors in a llama (Lama glama). J Vet Diagn Invest. 2010;22(5):808–11.CrossRefPubMedGoogle Scholar
  37. 37.
    Withrow SJ, Vail DM: Withrow & MacEwen’s small animal clinical oncology.5th ed. St Louis, United States: Saunders Elsevier, 2013, 20:335–55.Google Scholar
  38. 38.
    Book AP, Fidel J, Wills T, Bryan J, Sellon R, Mattoon J. Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors. Vet Radiol Ultrasound. 2011;52(5):548–54.CrossRefPubMedGoogle Scholar
  39. 39.
    Tsujimura T, Furitsu T, Morimoto M. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood. 1994;83:2619–26.PubMedGoogle Scholar
  40. 40.
    Schumacher JA, Elenitoba-Johnson KS, Lim MS. Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR. J Clin Pathol. 2008;61:109–14.CrossRefPubMedGoogle Scholar
  41. 41.
    Letard S, Yang Y, Hanssens K. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol Cancer Res. 2008;6:1137–45.CrossRefPubMedGoogle Scholar
  42. 42.
    Webster JD, Kiupel M, Kaneene JB. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol. 2004;41:371–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Gilda Costa RM, Matos E, Rema A, Lopes C, Pires MA, Gärtner F. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. BMC Vet Res. 2007;3:19.CrossRefGoogle Scholar
  44. 44.
    Passantino L, Passantino G, Cianciotta A, Ribaud MR, Lo Presti G, Ranieri G, et al. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors. Immunopharmacol Immunotoxicol. 2008;30(3):609–21.CrossRefPubMedGoogle Scholar
  45. 45.
    Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JH, Kiupel M. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia. 2006;8(2):104–11.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Maiolino P, De Vico G, Restucci B. Expression of vascular endothelial growth factor in basal cell tumours and in squamous cell carcinomas of canine skin. J Comp Pathol. 2000;123(2–3):141–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Restucci B, Maiolino P, Paciello O, Martano M, De Vico G, Papparella S. Evaluation of angiogenesis in canine seminomas by quantitative immunohistochemistry. J Comp Pathol. 2003;128(4):252–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Preziosi R, Sarli G, Paltrinieri M. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog. J Comp Pathol. 2004;130(2–3):143–51.CrossRefPubMedGoogle Scholar
  49. 49.
    Gross TL, Ihrke PJ, Walder EJ, Affolter VR: Epithelial neoplasms and other tumors. 2nd edition. Blackwell Publishing: Skin diseases of the dog and cat: clinical and histopathologic diagnosis; 2005:641–54.Google Scholar
  50. 50.
    Bronden LB, Eriksen T, Kristensen AT. Mast cell tumours and other skin neoplasia in Danish dogs—data from the Danish Veterinary Cancer Registry. Acta Vet Scand. 2010;22:52–6.Google Scholar
  51. 51.
    Noli C, Miolo A. The mast cell in wound healing. Vet Dermatol. 2001;12:303–13.CrossRefPubMedGoogle Scholar
  52. 52.
    Javanbakht J, Pedram B, Taheriyan MR, Khadivar F, Hosseini SH, Abdi FS, et al. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy. Tumour Biol. 2014;35(6):5493–500.CrossRefPubMedGoogle Scholar
  53. 53.
    Manesh JY, Shafiee R, Pedram B, Malayeri HZ, Mohajer S, Ahmadi S, Ahmadi S, Javanbakht J, Mokarizadeh A, Khadivar F. Improving the diagnosis, treatment, and biology patterns of feline mammary intraepithelial lesions: a potential model for human breast masses with evidence from epidemiologic and cytohistopathologic studies. Tumour Biol 2014 Aug 21.Google Scholar
  54. 54.
    Khaki F, Javanbakht J, Sharifzad S, Gharagozlou MJ, Khadivar F, Manesh JY, et al. Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy. J Ovarian Res. 2014;7(1):33.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Ehsan Hosseini
    • 1
  • Behnam Pedram
    • 2
  • Ali Mohammad Bahrami
    • 1
  • Seyed Rashid Touni
    • 3
  • Hamed Zamankhan Malayeri
    • 4
  • Aram Mokarizadeh
    • 5
  • Mehdi Pourzaer
    • 6
  • Maryam Pourzaer
    • 7
  • Shahram Zehtabian
    • 8
  • Sheida Mohajer
    • 9
  • Sharareh Ahmadi
    • 10
  1. 1.Faculty of Para Veterinary MedicineIlam UniversityIlamIran
  2. 2.Department of Pathobiology, Susangerd BranchIslamic Azad UniversitySusangerdIran
  3. 3.Department of Basic Science, Faculty of Veterinary MedicineUrmia UniversityUrmiaIran
  4. 4.Department of Internal Medicine, Faculty of Veterinary MedicineTehran UniversityTehranIran
  5. 5.Department of Immunology, Faculty of Medicine, and Cellular and Molecular Research CenterKurdistan University of Medical SciencesSanandajIran
  6. 6.Faculty of Veterinary Science, Karaj BranchIslamic Azad UniversityAlborzIran
  7. 7.Department of Biology, Faculty of Basic Science, Damghan BranchIslamic Azad UniversityDamghanIran
  8. 8.Department of Microbiology, Faculty of MedicineKermanshah University of Medical SciencesKermanshahIran
  9. 9.Chronic Respiratory Disease Research Center, National Research Institue of Tuberculosis and Lung Diseases, Massih Daneshvary HospitalShahid Beheshti University of MedicineTehranIran
  10. 10.Faculty of MedicineKermanshah University of Medical SciencesKermanshahIran

Personalised recommendations